You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


BMS inks drug discovery deal with Schrödinger

Bristol Myers Squibb will pay $55m upfront to American life sciences company Schrödinger to access its drug discovery platform.